Bioequivalence is a term in pharmacokinetics used to assess the expected in vivo biological equivalence of generic version to its proprietary version of a drug or formulations of innovator drug in different clinical trial phases.
GenBiosis clinical trial team consists of highly experienced and qualified professionals and is well versed and experienced in most of the therapeutic indications which cater sponsor needs for Phase I, Phase IIa / Phase IIb and Phase III studies and has project management expertise to deliver the trials. We believe to conduct trials with experience hands and ensure to comply with global clinical trial requirements.
Our medical writing team is dedicated to provide high-quality, scientifically accurate and regulatory-compliant study protocols & reports. With a team of experienced writers, we specialize in crafting clear and concise medical and scientific content tailored to the needs of the specific regulatory agency.
Our team has expertise in assessing emerging regulatory trends, developing strategies and defining process improvement that facilitates drug approval & registration process.
info@gen-biosis.com
Corporate office and BA/BE Centre, Majestic Plaza, Sr. No. 21/5, Near Manipal Hospital, Kharadi, Pune – 411 014, Maharashtra.
© 2026 GenBiosis. All Rights Reserved.